ENTRADA THERAPEUTICS INC (TRDA) Stock Balance Sheet
NASDAQ:TRDA - Nasdaq - US29384C1080 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 67.84M | 101.21M | 67.60M | 45.20M | 291.10M | |||
| Marketable Securities | 314.68M | 318.79M | 284.37M | 143.60M | N/A | |||
| Receivables | 2.04M | 3.68M | 5.88M | N/A | N/A | |||
| Other Current Assets | 18.63M | 16.36M | 11.92M | 21.20M | 7.60M | |||
| Total Current Assets | 403.19M | 440.04M | 369.77M | 209.90M | 298.70M | |||
| Non-Current Assets | ||||||||
| PPE Net | 79.10M | 82.05M | 92.68M | 33.00M | 6.30M | |||
| Other Non-Current Assets | 4.19M | 4.23M | 6.74M | 9.20M | 900.00K | |||
| Total Non-Current Assets | 83.29M | 86.28M | 99.42M | 42.20M | 7.10M | |||
| TOTAL ASSETS | 486.48M | 526.32M | 469.19M | 252.10M | 305.80M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 14.09M | 20.90M | 19.23M | 16.00M | 6.00M | |||
| Accounts Payable | 2.19M | 4.26M | 3.28M | 6.00M | 700.00K | |||
| Other Current Liabilities | 2.15M | 14.32M | 136.28M | N/A | N/A | |||
| Total Current Liabilities | 18.43M | 39.48M | 158.80M | 22.00M | 6.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 50.79M | 58.16M | 68.04M | 17.50M | 400.00K | |||
| Total Non-Current Liabilities | 50.79M | 58.16M | 68.04M | 17.50M | 400.00K | |||
| TOTAL LIABILITIES | 69.22M | 97.64M | 226.83M | 39.50M | 7.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -146.69M | -129.34M | -194.97M | -188.30M | -93.70M | |||
| Additional Paid In Capital | 563.51M | 558.06M | 437.13M | 402.90M | 392.40M | |||
| Common Shares | 4.00K | 4.00K | 3.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 437.00K | -43.00K | 195.00K | -2.10M | N/A | |||
| Shares Outstanding | 37.94M | 37.57M | 33.44M | 31.40M | 31.20M | |||
| Tangible Book Value per Share | 11.00 | 11.41 | 7.25 | 6.77 | 9.57 | |||
| Total Shareholders' Equity | 417.26M | 428.68M | 242.36M | 212.60M | 298.70M | |||
| TOTAL LIABILITIES AND EQUITY | 486.48M | 526.32M | 469.19M | 252.10M | 305.80M | |||
| Statistics | ||||||||
| Current Ratio | 21.88 | 11.15 | 2.33 | 9.54 | 44.58 | |||
| Return On Assets (ROA) | 5.09% | 12.47% | -1.42% | -37.53% | -16.73% | |||
| Return On Equity (ROE) | 5.94% | 15.31% | -2.76% | -44.51% | -17.13% | |||
| Return On Invested Capital (ROIC) | 0.69% | 7.63% | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | 3.79% | 55.56% | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 3.79% | 55.56% | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21